ReviewMolecules (Basel, Switzerland)2026
The 1,5-Benzodiazepin-2-Ones: A Review on Synthetic Strategies, Reactivity and Functional Applications.
Review in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
1,5-Benzodiazepin-2-one is a significant class of heterocyclic compounds that have attracted considerable attention due to these versatile scaffolds and their multifunctional properties. Owing to the presence of a fused benzene-diazepine core, these compounds display rich chemical reactivity and various physicochemical characteristics, making them valuable structures in both fundamental and applied research. This review provides a comprehensive and critical overview of the advances reported to date on 1,5-benzodiazepin-2-ones, with particular emphasis on their diverse synthetic methodologies, reaction mechanisms, and structure-property relationships. Classical and modern synthetic approaches are discussed, including condensation reactions, multicomponent processes, catalytic and green chemistry approaches, as well as recent developments toward more sustainable and efficient protocols. The intrinsic reactivity of the 1,5-benzodiazepin-2-one framework enables access to structurally diverse derivatives. Furthermore, the review summarizes the broad range of applications of these heterocycles, especially in medicinal chemistry, where they have demonstrated significant biological activities, as well as in corrosion inhibition and photoluminescent materials. Finally, current challenges, limitations, and future perspectives are outlined to provide guidance for further research and development of 1,5-benzodiazepin-2-one-based systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.